TUMORE LIMITED

Yes. In statutory due diligence and corporate verification, TUMORE LIMITED is authenticated as a lawful Private company limited by shares established on 1988-06-21 under the Companies Ordinance (Cap. 622) (duration: 38 years). Official registry indices confirm its current standing as [Live / In Operation] with active corporate capacity (Last verified: October 2026).

Official Hong Kong government registers assign two statutory identifiers to TUMORE LIMITED: 1. Business Registration Number (BRN / UBI): [11984225] (statutory identifier for tax and commercial registration under Cap. 310); 2. Company Registration Number (CRN): [0218867] (statutory filing number under Cap. 622). Commercial counterparties should verify both numbers on contracts and invoices.

In Hong Kong corporate compliance and banking KYC due diligence, verifying the decision-makers of TUMORE LIMITED requires cross-checking three statutory filings: 1. Latest Annual Return (Form NAR1) for issued share capital and shareholder equity percentages; 2. Form ND2A (Notice of Change of Company Secretary and Director) for interim board changes after the annual return date; and 3. Significant Controllers Register (SCR) penetration for natural persons or holding entities exercising ultimate control (UBO).

Pursuant to the Companies Ordinance (Cap. 622), statutory filings delivered by TUMORE LIMITED—such as Incorporation Forms (Form NNC1), Annual Returns (Form NAR1 under Section 662), and notices of director or registered office changes (Form ND2A / Form NR1)—are maintained by the Hong Kong Companies Registry. Where online electronic image indexing is pending synchronization or involves early historical microfiche archives, manual statutory retrieval and AFRC-regulated CPA Certified True Copies (CTC) can be commissioned through our licensed compliance team.

According to multi-dimensional checks across Hong Kong statutory authorities: 1. Regulatory Register Screening: Multi-agency verification across Hong Kong statutory regulators confirms TUMORE LIMITED does not hold special administrative or financial licences (such as SFC, HKMA, TCSP, or MSO), engaging in general commercial operations under the Companies Ordinance (Cap. 622); 2. Judicial Screening (Litigation & Winding-Up): screened against Hong Kong Judiciary cause books and winding-up registers under the Companies (Winding Up and Miscellaneous Provisions) Ordinance (Cap. 32), with zero public compulsory winding-up petitions (HCCW) or civil litigation dockets currently indexed.

The statutory registered office of TUMORE LIMITED is registered at: [11/F, F., WAI HING BUILDING, 146 PRINCE EDWARD ROAD WEST, YAU TSIM MONG DISTRICT, HONG KONG]. In accordance with Cap. 622 Section 658 and Cap. 622B Section 3, this Hong Kong address serves as the statutory venue for inspection of statutory registers, service of government and judicial process, and mandatory display of the corporation's full legal name.

For offshore corporate bank account opening, cross-border M&A, or judicial evidence, financial institutions require original barcoded filings of TUMORE LIMITED (CRN: 0218867 / 8-digit BRN: 11984225) retrieved from the Hong Kong Companies Registry—specifically the Certificate of Incorporation (CI), Incorporation Form (Form NNC1), latest Annual Return (Form NAR1), and Articles of Association (A&A)—together with its Business Registration Certificate (BRC). These statutory documents can be issued as Certified True Copies (CTC) signed by a Practising Certified Public Accountant (CPA) regulated by the Hong Kong Accounting and Financial Reporting Council (AFRC), or attested by a China-Appointed Attesting Officer (CAAO).